Published work

---

For an updated publication list, please see: weblink

• Combined Loss of Obsc and Obsl1 in Murine Hearts Results in Diastolic Dysfunction, Altered Metabolism, and Deregulated Mitophagy.
  
• Fujita K, Desmond P, Blondelle J, Soták M, Rajan MR, Clark M, Estève É, Chan Y, Gu Y, Actis Dato V, Marrocco V, Dalton ND, Ghassemian M, Do A, Klos M, Peterson KL, Sheikh F, Cho Y, Börgeson E, Lange S.
  Circ Heart Fail. 2025 Apr;18(4):e011867. doi: 10.1161/CIRCHEARTFAILURE.124.011867. Epub 2025 Mar 11.
  PMID: 40066567 Free PMC article.
  
• SERPINA3C as a mediator of metabolic health in offspring.
  Suur BE, Börgeson E.
  Nat Metab. 2025 Feb;7(2):245-246. doi: 10.1038/s42255-024-01209-2.
  PMID: 39891021 No abstract available.
• Inflammation and resolution in obesity.
  Soták M, Clark M, Suur BE, Börgeson E.
  Nat Rev Endocrinol. 2025 Jan;21(1):45-61. doi: 10.1038/s41574-024-01047-y. Epub 2024 Oct 24.
  PMID: 39448830 Review.
  
• The challenges of assessing adiposity in a clinical setting.
  Börgeson E, Tavajoh S, Lange S, Jessen N.
  Nat Rev Endocrinol. 2024 Jul 15. doi: 10.1038/s41574-024-01012-9. PMID: 39009863
• Attenuation of adipose tissue inflammation by pro-resolving lipid mediators
  Madison Clark, Bianca E. Suur, Matúš Soták, Emma Börgeson
  Current Opinion in Endocrine and Metabolic Research, 2024, 100539, ISSN 2451-9650, doi: 10.1016/j.coemr.2024.100539.
• The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity.
  AlZaim I, de Rooij LPMH, Sheikh BN, Börgeson E, Kalucka J.
  Nat Rev Endocrinol. 2023 Dec;19(12):691-707. doi: 10.1038/s41574-023-00893-6. Epub 2023 Sep 25. PMID: 37749386
• Students at a crossroad: A cross-sectional survey gauging the impact of COVID-19 on medical and biomedical graduates in the United States and Sweden.
  Lange S, Soták M, Hagberg CE, Bagunu G, Vigmo S, Börgeson E. 
  Biochem Mol Biol Educ. 2023 Jun 24;. doi: 10.1002/bmb.21761. [Epub ahead of print] PubMed PMID: 37354049.
• Of mice and men: Pinpointing species differences in adipose tissue biology.
  Börgeson E, Boucher J, Hagberg CE.  Front Cell Dev Biol. 2022;10:1003118.
  doi: 10.3389/fcell.2022.1003118. eCollection 2022. Review. PubMed PMID: 36187476; PubMed Central PMCID: PMC9521710.
• Lipoxins reduce obesity-induced adipose tissue inflammation in 3D-cultured human adipocytes and explant cultures.
  Soták M, Rajan MR, Clark M, Harms M, Rani A, Kraft JD, Tandio D, Shen T, Borkowski K, Fiehn O, Newman JW, Quiding-Järbrink M, Biörserud C, Apelgren P, Staalesen T, Hagberg CE, Boucher J, Wallenius V, Lange S, Börgeson E. 
  iScience. 2022 Jul 15;25(7):104602. doi: 10.1016/j.isci.2022.104602. eCollection 2022 Jul 15. PubMed PMID: 35789845; PubMed Central PMCID: PMC9249816.
• The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development.
  Picarda E, Galbo PM Jr, Zong H, Rajan MR, Wallenius V, Zheng D, Börgeson E, Singh R, Pessin J, Zang X.  Sci Adv.
  2022 Apr 29;8(17):eabm7012. doi: 10.1126/sciadv.abm7012. Epub 2022 Apr 27. PubMed PMID: 35476450; PubMed Central PMCID: PMC9045715.
• Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis.
  Kraft JD, Blomgran R, Bergström I, Soták M, Clark M, Rani A, Rajan MR, Dalli J, Nyström S, Quiding-Järbrink M, Bromberg J, Skoog P, Börgeson E. 
  FASEB J. 2022 Mar;36(3):e22173. doi: 10.1096/fj.202101219RR. PubMed PMID: 35104001; PubMed Central PMCID: PMC9305188.
• Healthy Subcutaneous and Omental Adipose Tissue Is Associated with High Expression of Extracellular Matrix Components.
  Soták M, Rajan MR, Clark M, Biörserud C, Wallenius V, Hagberg CE, Börgeson E.
  Int J Mol Sci. 2022 Jan 4;23(1). doi: 10.3390/ijms23010520. PubMed PMID: 35008946; PubMed Central PMCID: PMC8745535.
• The N2A region of titin has a unique structural configuration.
  Stronczek C, Lange S, Bullard B, Wolniak S, Börgeson E, Mayans O, Fleming JR.
  J Gen Physiol. 2021 Jul 5;153(7). doi: 10.1085/jgp.202012766. PubMed PMID: 33836065; PubMed Central PMCID: PMC8042602.
• Challenges in PhD education due to COVID-19 - disrupted supervision or business as usual: a cross-sectional survey of Swedish biomedical sciences graduate students.
  Börgeson E, Sotak M, Kraft J, Bagunu G, Biörserud C, Lange S. 
  BMC Med Educ. 2021 May 22;21(1):294. doi: 10.1186/s12909-021-02727-3. PubMed PMID: 34022871; PubMed Central PMCID: PMC8140581.
• Molecular Characterisation of Titin N2A and Its Binding of CARP Reveals a Titin/Actin Cross-linking Mechanism.
  Zhou T, Fleming JR, Lange S, Hessel AL, Bogomolovas J, Stronczek C, Grundei D, Ghassemian M, Biju A, Börgeson E, Bullard B, Linke WA, Chen J, Kovermann M, Mayans O.
  J Mol Biol. 2021 Apr 30;433(9):166901. doi: 10.1016/j.jmb.2021.166901. Epub 2021 Feb 27. PubMed PMID: 33647290; PubMed Central PMCID: PMC8052292.
• Specialized Pro-Resolving Mediators and the Lymphatic System.
  Kraft JD, Blomgran R, Lundgaard I, Quiding-Järbrink M, Bromberg JS, Börgeson E. 
  Int J Mol Sci. 2021 Mar 9;22(5). doi: 10.3390/ijms22052750. Review. PubMed PMID: 33803130; PubMed Central PMCID: PMC7963193.
• Exploring Obscurin and SPEG Kinase Biology.
  Fleming JR, Rani A, Kraft J, Zenker S, Börgeson E, Lange S.
  J Clin Med. 2021 Mar 2;10(5). doi: 10.3390/jcm10050984. PubMed PMID: 33801198; PubMed Central PMCID: PMC7957886.
• Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum.
  Rajan MR, Sotak M, Barrenäs F, Shen T, Borkowski K, Ashton NJ, Biörserud C, Lindahl TL, Ramström S, Schöll M, Lindahl P, Fiehn O, Newman JW, Perkins R, Wallenius V, Lange S, Börgeson E.
  Sci Rep. 2019 Oct 28;9(1):15385. doi: 10.1038/s41598-019-51673-0. PubMed PMID: 31659186; PubMed Central PMCID: PMC6817872.
• Obesity-induced changes in lipid mediators persist after weight loss.
  Hernandez-Carretero A, Weber N, La Frano MR, Ying W, Lantero Rodriguez J, Sears DD, Wallenius V, Börgeson E, Newman JW, Osborn O.
  Int J Obes (Lond). 2018 Apr;42(4):728-736. doi: 10.1038/ijo.2017.266. Epub 2017 Nov 1. PubMed PMID: 29089614; PubMed Central PMCID: PMC6055936.
• AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin.
  Börgeson E, Wallenius V, Syed GH, Darshi M, Lantero Rodriguez J, Biörserud C, Ragnmark Ek M, Björklund P, Quiding-Järbrink M, Fändriks L, Godson C, Sharma K.
  Diabetologia. 2017 Apr;60(4):729-739. doi: 10.1007/s00125-017-4211-9. Epub 2017 Feb 10. PubMed PMID: 28188334; PubMed Central PMCID: PMC6518112.
• The PARsylation activity of tankyrase in adipose tissue modulates systemic glucose metabolism in mice.
  Zhong L, Ding Y, Bandyopadhyay G, Waaler J, Börgeson E, Smith S, Zhang M, Phillips SA, Mahooti S, Mahata SK, Shao J, Krauss S, Chi NW. 
  Diabetologia. 2016 Mar;59(3):582-91. doi: 10.1007/s00125-015-3815-1. Epub 2015 Dec 2. PubMed PMID: 26631215.
• Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease.
  Börgeson E, Johnson AM, Lee YS, Till A, Syed GH, Ali-Shah ST, Guiry PJ, Dalli J, Colas RA, Serhan CN, Sharma K, Godson C. 
  Cell Metab. 2015 Jul 7;22(1):125-37. doi: 10.1016/j.cmet.2015.05.003. Epub 2015 Jun 4. PubMed PMID: 26052006; PubMed Central PMCID: PMC4584026.
• Obesity, immunomodulation and chronic kidney disease.
  Börgeson E, Sharma K.
  Curr Opin Pharmacol. 2013 Aug;13(4):618-24. doi: 10.1016/j.coph.2013.05.011. Epub 2013 Jun 7. Review. PubMed PMID: 23751262; PubMed Central PMCID: PMC4442271.
• IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responses.
  Corcoran JB, McCarthy S, Griffin B, Gaffney A, Bhreathnach U, Börgeson E, Hickey FB, Docherty NG, Higgins DF, Furlong F, Martin F, Godson C, Murphy M. 
  Biochim Biophys Acta. 2013 Aug;1833(8):1969-78. doi: 10.1016/j.bbamcr.2013.03.027. Epub 2013 Apr 6. PubMed PMID: 23567938.
• IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responses.
  Corcoran JB, McCarthy S, Griffin B, Gaffney A, Bhreathnach U, Börgeson E, Hickey FB, Docherty NG, Higgins DF, Furlong F, Martin F, Godson C, Murphy M. 
  Biochim Biophys Acta. 2013 Aug;1833(8):1969-78. doi: 10.1016/j.bbamcr.2013.03.027. Epub 2013 Apr 6. PubMed PMID: 23567938.
• Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications.
  Börgeson E, Godson C.
  Front Immunol. 2012;3:318. doi: 10.3389/fimmu.2012.00318. eCollection 2012. PubMed PMID: 23087692; PubMed Central PMCID: PMC3474937.
• Lipoxin A4 attenuates adipose inflammation. FASEB J.
  Börgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF, Maderna P, Roche HM, Godson C.
  2012 Oct;26(10):4287-94. doi: 10.1096/fj.12-208249. Epub 2012 Jun 14. PubMed PMID: 22700871.
• Lipoxin A₄ and benzo-lipoxin A₄ attenuate experimental renal fibrosis.
  Börgeson E, Docherty NG, Murphy M, Rodgers K, Ryan A, O'Sullivan TP, Guiry PJ, Goldschmeding R, Higgins DF, Godson C. 
  FASEB J. 2011 Sep;25(9):2967-79. doi: 10.1096/fj.11-185017. Epub 2011 May 31. PubMed PMID: 21628447.
• Lipoxin A₄ inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression.
  Börgeson E, Lönn J, Bergström I, Brodin VP, Ramström S, Nayeri F, Särndahl E, Bengtsson T.
  Infect Immun. 2011 Apr;79(4):1489-97. doi: 10.1128/IAI.00777-10. Epub 2011 Jan 24. PubMed PMID: 21263017; PubMed Central PMCID: PMC3067532.
• Molecular circuits of resolution in renal disease.
  Börgeson E, Godson C.
  ScientificWorldJournal. 2010 Jul 7;10:1370-85. doi: 10.1100/tsw.2010.120. Review. PubMed PMID: 20623097; PubMed Central PMCID: PMC5763933.

---